CERS Earnings Date: Nov 2, 2026 (Estimated) — Cerus Corporation
NASDAQ · Healthcare · Medical Devices
Updated
When is CERS's next earnings date?
Cerus Corporation (CERS) is expected to report Q3 2026 earnings on Monday, November 2, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.01 on revenue of $63.3M.
How did CERS do in its last earnings report?
In its most recent report on Jul 30, 2026 (Q2 2026), Cerus Corporation posted EPS of -$0.01 versus the -$0.01 estimate, an in-line result. Revenue was $57.4M against a $58.9M estimate. The stock's 1-day post-earnings move was -25.6%.
How much does CERS stock move after earnings?
CERS beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 15.7% (up or down) in the day after earnings.
About Cerus Corporation
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell components. Furthermore, Cerus markets an INTERCEPT Blood System for Cryoprecipitation, which leverages its plasma technology to produce two key pathogen-reduced blood products: a cryoprecipitated fibrinogen complex for treating and controlling bleeding, particularly massive hemorrhages stemming from fibrinogen deficiency, and pathogen-reduced, cryoprecipitate-reduced plasma. Cerus distributes these platelet and plasma systems globally through a combination of its direct sales force and an extensive network of distributors, reaching markets in North America, Europe, the Commonwealth of Independent States, the Middle East, and Latin America. Established in 1991, Cerus Corporation maintains its corporate headquarters in Concord, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | Q2 2026 | -0.01 | -0.01 | +0.00% | $57.4M | ➖ Inline | -25.61% | -19.72% | -8.30% |
| 2026-04-30 | Q1 2026 | -0.03 | -0.01 | +66.67% | $53.7M | ✅ Beat | +33.99% | +28.57% | +39.90% |
| 2026-03-02 | Q4 2025 | -0.01 | -0.01 | +0.00% | $57.8M | ➖ Inline | -15.81% | -23.72% | -28.06% |
| 2025-11-06 | Q3 2025 | -0.02 | 0.00 | +100.00% | $52.7M | ✅ Beat | +21.28% | +13.48% | +32.62% |
| 2025-08-05 | Q2 2025 | -0.02 | -0.03 | -50.00% | $52.4M | ❌ Miss | +0.78% | +0.78% | +3.91% |
| 2025-02-20 | Q4 2024 | -0.01 | -0.01 | +0.00% | $50.8M | ➖ Inline | -5.17% | -8.62% | -12.07% |
| 2024-08-01 | Q2 2024 | -0.04 | -0.03 | +25.00% | $45.1M | ✅ Beat | +14.95% | +6.86% | +10.78% |
| 2024-05-02 | Q1 2024 | -0.05 | -0.05 | +0.00% | $38.4M | ➖ Inline | -7.95% | +8.52% | +0.57% |
Showing last 8 quarters.